Matthew Henn
Technik-/Wissenschafts-/F&E-Leiter bei SERES THERAPEUTICS, INC.
Vermögen: 47 133 $ am 30.04.2024
Aktive Positionen von Matthew Henn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SERES THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.02.2019 | - |
| Corporate Officer/Principal | 01.06.2012 | 07.02.2019 |
Karriereverlauf von Matthew Henn
Ehemalige bekannte Positionen von Matthew Henn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.03.2005 | 01.06.2012 |
| Viral Genomics, Inc. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Matthew Henn
| University of California, Berkeley | Doctorate Degree |
| University of New Hampshire | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SERES THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
| Viral Genomics, Inc. |
- Börse
- Insiders
- Matthew Henn
- Erfahrung
